Plato Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.45M Buy
40,430
+14,702
+57% +$1.31M 0.23% 101
2025
Q4
$2.04M Hold
25,728
0.13% 161
2025
Q3
$2.04M Hold
25,728
0.14% 159
2025
Q2
$2.33M Buy
25,728
+21
+0.1% +$1.92K 0.18% 127
2025
Q1
$2.43M Buy
25,707
+177
+0.7% +$15.8K 0.21% 120
2024
Q4
$2.33M Buy
25,530
+5,378
+27% +$513K 0.17% 128
2024
Q3
$2.09M Hold
20,152
0.17% 147
2024
Q2
$1.96M Buy
20,152
+1,311
+7% +$121K 0.18% 125
2024
Q1
$1.7M Buy
18,841
+16,706
+782% +$1.42M 0.18% 143
2023
Q4
$170K Buy
+2,135
New +$161K 0.21% 114

Other funds holding CL

Plato Investment Management's CL Position: Q1 2026 in Review

Plato Investment Management increased its Colgate-Palmolive (CL) stake by 57% in Q1 2026, buying an estimated $1.31M and bringing the position to 40,430 shares worth $3.45M. The position accounts for 0.23% of the portfolio, ranked #101.

Plato Investment Management first reported a position in CL in Q4 2023 and has held it in 10 quarters since. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Plato Investment Management held 40,430 shares of Colgate-Palmolive worth $3.45M as of Q1 2026.
  • Plato Investment Management bought 14,702 Colgate-Palmolive shares in Q1 2026, an estimated $1.31M.
  • Colgate-Palmolive made up 0.23% of Plato Investment Management's portfolio in Q1 2026, its #101 holding.
  • Plato Investment Management first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 10 quarters since.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.